#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13784	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2143	639.3	0	.	n	.	0	C451T	SNP	451	451	C	710	710	T	796	T,C	679,64	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13784	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2143	639.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1443	1443	C	851	C	787	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24886	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3456	716.6	0	.	n	.	0	T695C	SNP	695	695	T	1009	1009	C	752	C,T	693,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24886	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3456	716.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2285	2285	C	764	C,A	703,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24886	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3456	716.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2359	2359	A	726	A,G	678,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24886	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3456	716.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2911	2911	C	772	C,T	720,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24886	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3456	716.6	0	HET	.	.	.	G2616A,T	.	2616	2616	G	2930	2930	G	755	G,A,T	548,165,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24886	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3456	716.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1952	1952	A	890	A,G	614,196	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1834	folP	855	855	100.0	folP.l15.c4.ctg.1	1460	124.9	1	SNP	p	R229S	1	.	.	685	687	AGC	963	965	AGC	196;195;195	A;G;C	173;172;173	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4884	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3395	143.5	1	SNP	p	S91F	1	.	.	271	273	TTC	596	598	TTC	188;185;182	T;T;C	173;174;169	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4884	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3395	143.5	1	SNP	p	D95G	1	.	.	283	285	GGC	608	610	GGC	185;186;187	G;G;C	169;171;172	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4884	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3395	143.5	1	SNP	p	G95N	0	.	.	283	285	GGC	608	610	GGC	185;186;187	G;G;C	169;171;172	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1552	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1375	112.1	1	SNP	p	G45D	0	.	.	133	135	GGC	417	419	GGC	175;172;173	G;G;C	160;160;158	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	788	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	917	85.1	0	.	n	.	0	A197.	DEL	197	197	A	558	558	A	195	A	180	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4594	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	155.8	1	SNP	p	D86N	0	.	.	256	258	GAC	551	553	GAC	184;185;187	G;A;C	171;168;175	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4594	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	155.8	1	SNP	p	R87I	0	.	.	259	261	CGT	554	556	CGT	189;189;189	C;G;T	178;180;177	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4594	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	155.8	1	SNP	p	S87R	1	.	.	259	261	CGT	554	556	CGT	189;189;189	C;G;T	178;180;177	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4594	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	155.8	1	SNP	p	R87W	0	.	.	259	261	CGT	554	556	CGT	189;189;189	C;G;T	178;180;177	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4594	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	155.8	1	SNP	p	S88P	0	.	.	262	264	TCC	557	559	TCC	189;189;191	T;C;C	177;181;183	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3884	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2425	158.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1446	1448	GGC	193;190;192	G;G;C	184;177;178	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1239	1241	GCC	202;201;201	G;C,T;C	188;186,1;186	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1242	1244	ATG	200;205;201	A;T;G	187;191;188	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1254	1256	ACC	190;191;192	A,G;C;C	172,1;176;176	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1254	1256	ACC	190;191;192	A,G;C;C	172,1;176;176	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1755	1757	ACC	192;195;200	A;C;C	172;181;186	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1809	1811	GCG	201;201;204	G,T;C;G	188,1;189;191	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1809	1811	GCG	201;201;204	G,T;C;G	188,1;189;191	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1932	1934	GGT	154;156;154	G;G;T	143;145;142	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1941	1943	AGC	142;142;140	A;G;C	129;129;125	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3686	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	150.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1959	1961	CCG	131;133;136	C,G;C,G;GCCC,GGCCCC	95,8;99,2;92,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5236	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3062	170.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1606	1608	CCG	193;195;197	C;C;G	169;178;173	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1928	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1829	104.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	499	499	C	118	C	114	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1655	169.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1040	1042	AGA	234;232;229	A,G;G;A	194,26;221;218	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1655	169.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1061	1063	GGT	224;225;219	G,A;G;T	190,28;217;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1655	169.6	1	SNP	p	G120K	1	.	.	358	360	AAG	770	772	AAG	216;215;214	A,G;A;G	200,1;201;197	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1655	169.6	1	SNP	p	N121D	0	.	.	361	363	AAC	773	775	AAC	216;215;218	A;A;C	197;202;205	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1655	169.6	1	SNP	p	A121N	1	.	.	361	363	AAC	773	775	AAC	216;215;218	A;A;C	197;202;205	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10086	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4914	204.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1064	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1173	90.4	1	SNP	p	V57M	1	.	.	169	171	ATG	649	651	ATG	224;227;229	A;T;G	212;212;214	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
